METTL3通过m6的瘤性lncRNAs的A-依赖调制来协调癌症的进展
Xinyi Qian1, Xufan Li1, Zhihong Zheng2
1Department of Respiratory Medicine, Sir Run Run Shaw Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, China.
International journal of biological macromolecules
|April 19, 2025
概括
这项研究揭示了METTL3作为长非编码RNA (lncRNAs) 中N6-甲基氨酸 (m6A) 修饰的关键调节者. 经METTL3修饰的lncRNAs (mmlncRs) 显示出作为癌症治疗点的潜力.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- N6-甲基氨酸 (m6A) 是一种影响基因表达的关键RNA修饰,主要研究在mRNA中.
- 在调节长非编码RNA (lncRNAs) 中m6A的作用尚不清楚.
- 了解m6A对lncRNAs的影响对于破译癌症等疾病中复杂的基因调节网络至关重要.
研究的目的:
- 调查各种癌症类型中 lncRNA表达中的m6A修饰的调节格局.
- 为了确定关键的m6A调节器及其向瘤中涉及的lncRNAs.
- 阐明特定的m6A修饰 lncRNAs 在癌症进展中的功能和机制作用.
主要方法:
- 在12种癌症类型的6219个癌症样本中对m6A调节器和lncRNA进行了全面分析.
- 使用RNA测序 (RNA-seq) 和m6A特异性免疫沉测序 (MeRIP-seq).
- 进行了功能测定,包括基因淘汰实验,以评估METTL3对癌细胞的影响.
主要成果:
- 在19个研究的m6A调节者中,METTL3被确定为lncRNA表达的最重要的调节者.
- 在12种癌症类型中发现了397种METTL3介导的m6A修饰的lncRNAs (mmlncRs).
- METTL3淘汰抑制了肺癌细胞的增殖;C1RL-AS1被确定为METTL3的瘤性m6A标,其稳定性取决于YTHDF2结合.
结论:
- METTL3在lncRNA m6A修饰中起着至关重要的作用,并影响癌症的进展.
- mmlncRs代表了一类新的调节分子,具有作为癌症生物标志物和治疗点的潜力.
- 这项研究为了解瘤学中METTL3驱动的lncRNA调节提供了基础资源.
相关概念视频
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Cancer Stem Cells and Tumor Maintenance
4.6K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.6K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K


